AJJ Medtech Holdings Limited has announced that its subsidiary, AJJ Healthcare Management Pte Ltd, has been awarded a significant long-term supply contract by a prominent network of Singapore healthcare institutions. The contract, effective from 22 October 2025 to 21 October 2028, involves the provision of laboratory plastic consumables to several national-level research and clinical institutions, with an option for a two-year extension.
The contract underscores AJJ Healthcare’s reputation for high-quality and reliable supply chain management, reinforcing its standing as a trusted MedTech and healthcare brand in Singapore. This development is seen as a strategic move that strengthens the company’s position in the institutional supply sector, enhancing its recurring revenue base and earnings visibility over the medium term.
AJJ Healthcare’s CEO, William Ong, expressed his enthusiasm about the contract, stating, “This strategic award enables us to further demonstrate our commitment to operational excellence and supply chain reliability. We are honoured to expand our partnership with Singapore’s leading healthcare institutions.”
The contract also highlights the company’s capability to meet stringent supply chain requirements whilst maintaining consistent product quality and service reliability. AJJ Healthcare’s ISO 13485-certified quality framework played a crucial role in securing this contract, further validating its commercial operations.
The company anticipates that this contract will contribute positively to its financial performance, although the actual revenue generated may vary due to market or regulatory changes. AJJ Medtech Holdings Limited plans to provide updates on any material developments related to this contract.
